Showing results (71-80 of 124) with videos related to
Sort By:
Pageof 13
Journal of Clinical Immunology|October 17, 2020
Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring MyeloablationSharat Chandra, Shanmuganathan Chandrakasan, Blachy J Dávila Saldaña, et al.Pediatric Transplantation|January 4, 2014
The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patientsPooja Khandelwal, Julia Lawrence, Alexandra H Filipovich, et al.The Pediatric Infectious Disease Journal|October 11, 2022
Single Site Experience of the use of Monoclonal Antibodies for the Treatment of COVID-19 in High-risk Pediatric and Young Adult PatientsHannah Bahakel, Catherine Murphy, Robert W Frenck, et al.The Pediatric Infectious Disease Journal|January 13, 2023
Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children's HospitalZheyi Teoh, Lara Danziger-Isakov, Joshua D Courter, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 28, 2017
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant PatientsPooja Khandelwal, Ashley Teusink-Cross, Stella M Davies, et al.Cell Death & Disease|September 22, 2019
TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAPJanin Knop, Lisanne M Spilgies, Stefanie Rufli, et al.Cell Death & Disease|January 25, 2020
Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAPJanin Knop, Lisanne M Spilgies, Stefanie Rufli, et al.Pediatric Blood & Cancer|April 16, 2021
α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host diseaseAzada Ibrahimova, Stella M Davies, Adam Lane, et al.Blood Advances|July 8, 2020
Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disordersMark T Vander Lugt, Xiaohua Chen, Maria L Escolar, et al.Journal of Human Immunity|May 22, 2026
Expanding the scope of PI3K-δ inhibition: Leniolisib treatment in PRKCD deficiencyLorenzo Lodi, Valentina Guarnieri, Matilde Peri, et al.Pageof 13